EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

SGK1-Mediated Vascular Smooth Muscle Cell Phenotypic Transformation Promotes Thoracic Aortic Dissection Progression

Shuai Leng, Haijie Li, Pengfei Zhang, Zhiqiao Dang, Baowei Shao, Shishan Xue, Yansong Ning, Xilong Teng, Leilei Zhang, Honglu Wang, Na Li iD, Fengquan Zhang und 1 weitere

Arteriosclerosis, Thrombosis, and Vascular Biology · 2025-02 · 45 (2) · 238-259

DOI: 10.1161/atvbaha.124.321421 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2025-02. Verfasst von Shuai Leng und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery (S.L., H.L., P.Z., Z.D., B.S., S.X., Y.N., X.T., L.Z., H.W., N.L., F.Z., W.Y.), Central Hospital Affiliated to Shandong…. Hauptthemen laut MEDLINE: Immediate-Early Proteins, Muscle, Smooth, Vascular, Protein Serine-Threonine Kinases, Aortic Dissection. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The occurrence of thoracic aortic dissection (TAD) is closely related to the transformation of vascular smooth muscle cells (VSMCs) from a contractile to a synthetic phenotype. The role of SGK1 (serum- and glucocorticoid-regulated kinase 1) in VSMC phenotypic transformation and TAD occurrence is unclear. METHODS: Four-week-old male Sgk1 F/F ( Sgk1 floxed) and Sgk1 F/F ;Tagln Cre (smooth muscle cell–specific Sgk1 knockout) mice were administered β-aminopropionitrile monofumarate for 4 weeks to model TAD. The SGK1 inhibitor GSK650394 was administered daily via intraperitoneal injection to treat the mouse model of TAD. Immunopurification and mass spectrometry were used to identify proteins that interact with SGK1. Immunoprecipitation, immunofluorescence colocalization, and GST (glutathione S-transferase) pull-down were used to detect molecular interactions between SGK1 and SIRT6 (sirtuin 6). RNA-sequencing analysis was performed to evaluate changes in the SIRT6 transcriptome. Quantitative chromatin immunoprecipitation was used to determine the target genes regulated by SIRT6. Functional experiments were also conducted to investigate the role of SGK1-SIRT6-MMP9 (matrix metalloproteinase 9) in VSMC phenotypic transformation. The effect of SGK1 regulation on target genes was evaluated in human and mouse TAD samples. RESULTS: Sgk1 F/F ;Tagln Cre or pharmacological blockade of Sgk1 inhibited the formation and rupture of β-aminopropionitrile monofumarate–induced TADs in mice and reduced the degradation of the ECM (extracellular matrix) in vessels. Mechanistically, SGK1 promoted the ubiquitination and degradation of SIRT6 by phosphorylating SIRT6 at Ser338, thereby reducing the expression of the SIRT6 protein. Furthermore, SIRT6 transcriptionally inhibits the expression of MMP9 through epigenetic modification, forming the SGK1-SIRT6-MMP9 regulatory axis, which participates in the ECM signaling pathway. Additionally, our data showed that the lack of SGK1-mediated inhibition of ECM degradation and VSMC phenotypic transformation is partially dependent on the regulatory effect of SIRT6-MMP9. CONCLUSIONS: These findings highlight the key role of SGK1 in the pathogenesis of TAD. A lack of SGK1 inhibits VSMC phenotypic transformation by regulating the SIRT6-MMP9 axis, providing insights into potential epigenetic strategies for TAD treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immediate-Early ProteinsMuscle, Smooth, VascularProtein Serine-Threonine KinasesAortic DissectionMyocytes, Smooth MuscleAortic Aneurysm, ThoracicAorta, ThoracicAnimalsMalePhenotypeMice, KnockoutDisease Models, AnimalHumansMiceDisease ProgressionCells, CulturedSignal TransductionMatrix Metalloproteinase 9Vascular RemodelingMice, Inbred C57BLDissection, Thoracic AortaSerum-Glucocorticoid Regulated Kinases

Stichwörter der Autor:innen

dissection, thoracic aortamass spectrometrysequence analysis, RNAsirtuinsubiquitination

Substanzen

Immediate-Early ProteinsProtein Serine-Threonine KinasesMatrix Metalloproteinase 9Serum-Glucocorticoid Regulated Kinases

Autor:innen und Institutionen

  • Department of Cardiac Surgery (S.L., H.L., P.Z., Z.D., B.S., S.X., Y.N., X.T., L.Z., H.W., N.L., F.Z., W.Y.), Central Hospital Affiliated to Shandong First Medical University, Jinan, China.
  • Research Center of Translational Medicine (S.L., W.Y.), Central Hospital Affiliated to Shandong First Medical University, Jinan, China.

ORCID-Profile: Na Li, Wenqian Yu

Zitieren

APA

Leng, S., Li, H., Zhang, P., Dang, Z., Shao, B., Xue, S., Ning, Y., Teng, X., Zhang, L., Wang, H., Li, N., Zhang, F., & Yu, W. (2025). SGK1-Mediated Vascular Smooth Muscle Cell Phenotypic Transformation Promotes Thoracic Aortic Dissection Progression. Arteriosclerosis, Thrombosis, and Vascular Biology, 45(2), 238-259. https://doi.org/10.1161/atvbaha.124.321421

Vancouver

Leng S, Li H, Zhang P, Dang Z, Shao B, Xue S, et al. SGK1-Mediated Vascular Smooth Muscle Cell Phenotypic Transformation Promotes Thoracic Aortic Dissection Progression. Arteriosclerosis, Thrombosis, and Vascular Biology. 2025;45(2):238-259. doi:10.1161/atvbaha.124.321421

BibTeX
@article{Leng2025,
  author = {Leng, Shuai and Li, Haijie and Zhang, Pengfei and Dang, Zhiqiao and Shao, Baowei and Xue, Shishan and Ning, Yansong and Teng, Xilong and Zhang, Leilei and Wang, Honglu and Li, Na and Zhang, Fengquan and Yu, Wenqian},
  title = {SGK1-Mediated Vascular Smooth Muscle Cell Phenotypic Transformation Promotes Thoracic Aortic Dissection Progression},
  journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
  year = {2025},
  volume = {45},
  number = {2},
  pages = {238--259},
  doi = {10.1161/atvbaha.124.321421}
}
Kostenlos starten →